Wells Fargo Maintains Overweight on Exxon Mobil, Raises Price Target to $122
Wells Fargo analyst Roger Read maintains Exxon Mobil (NYSE:XOM) with a Overweight and raises the price target from $120 to $122.
Exxon Mobil Unusual Options Activity
Someone with a lot of money to spend has taken a bearish stance on Exxon Mobil (NYSE:XOM).
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Exxon Mobil Shows Strength Compared To The S&P 500: Here’s What’s Going On
Exxon Mobil Corporation (NYSE: XOM) closed up 2.23% higher Thursday, in contrast to the S&P 500, which declined 1.17%.
Tesla Short Sellers Earned $15.7B In Profits In 2022
Tesla Inc (NASDAQ: TSLA) was one of the worst-performing stocks in the market in 2022, but Tesla continued to be one of the best payoffs for short sellers.
Congressman Sells Stocks At End Of 2022 And Retires From Office: Taking Profits Or Warning Sign?
A member of Congress sold out of his positions of several stocks at the end of 2022. The move came as he finished his term serving the state of Texas and announced his retirement.
Analyst Ratings for Exxon Mobil
Over the past 3 months, 7 analysts have published their opinion on Exxon Mobil (NYSE:XOM) stock. These analysts…
This Is What Whales Are Betting On Exxon Mobil
A whale with a lot of money to spend has taken a noticeably bullish stance on Exxon Mobil.
Looking at options history for Exxon Mobil (NYSE:XOM) we detected 75 strange trades.
10 Best Stock Traders In Congress In 2022 (Spoiler: Nancy Pelosi Isn’t No. 1)
A new report was out about the performance of members of the U.S. Congress who bought and sold stocks and options in 2022.
The report broke down unusual trading activity from members of Congress and also showed the members who beat the returns of the S&P 500.
Here are the highlights of the report.
Barclays Maintains Overweight on Exxon Mobil, Raises Price Target to $129
Barclays analyst Jeanine Wai maintains Exxon Mobil (NYSE:XOM) with a Overweight and raises the price target from $111 to $129.